By Belinda Hickman
鈥楨nsuring kidney health is a priority for our company and obtaining this dedicated PLA code is a crucial milestone in our strategy to improve access to meaningful diagnostic tests.鈥橮roteomics International managing director Dr Richard Lipscombe
Catching early signs of diabetic kidney disease means patients can receive preventive care well before they develop costly and life-threatening end-stage kidney disease, avoiding the need for dialysis or a kidney transplant.
The simple finger-prick blood test could potentially throw a lifeline to more than 32 million Americans living with type 2 diabetes, given more than half of all adults with diabetes in the US will develop kidney complications. These cases contribute to a colossal US$130 billion in annual healthcare costs – more than a quarter of the nation鈥檚 Medicare budget.
Proteomics International managing director Dr Richard Lipscombe said: 鈥淓nsuring kidney health is a priority for our company and obtaining this dedicated PLA code is a crucial milestone in our strategy to improve access to meaningful diagnostic tests. Expanding access to PromarkerD will help to improve kidney health for patients everywhere.鈥
The PLA code is widely used across America鈥檚 complex health insurance system to report the use of medical procedures and services. It also allows insurers to monitor their use.